Tuesday, November 26, 2013
S.C. Rep. Stephen Goldfinch is facing federal charges after an investigation into alleged mislabeling during stem cell harvesting.
Goldfinch, of Murrells Inlet, is also involved in the biochemistry industry. He started a company called CureSource and later started another company called Caledonia Consulting LLC with a partner.
Both companies, after seeking approval from patients, harvested umbilical cords for research purposes, Goldfinch said Tuesday.
“As we grew, we hired an independent contractor, Dr. Vincent Dammai, to work directly with the laboratory research. We sold Caledonia while I was in my second year of law school,” Goldfinch said. He said the company sold for $1.2 million.
Earlier this year, Damai - a Texas-based molecular biologist and former MUSC professor - pleaded guilty to a misdemeanor charge of “mislabeling stem cells.”
Goldfinch said Damai caused the introduction of stem cells into interstate commerce without the approval of the Food and
Drug Administration (FDA).
The U.S. Attorney's Office in Texas is expected to charge Goldfinch with mislabeling and misbranding, he said.
“Unfortunately, the FDA regulations differ from state laws, and provide that partners, like myself, are responsible for their employees or independent contractors, regardless of knowledge or intent,” Goldfinch said. “Therefore, I will have no choice but to plead guilty, since I was a partner and did have responsibility for my wayward contractor.” Read more in Wednesday's Georgetown Times.
South Strand News is pleased to offer readers the enhanced ability to comment on stories. We expect our readers to engage in lively, yet civil discourse. We do not edit user submitted statements and we cannot promise that readers will not occasionally find offensive or inaccurate comments posted in the comments area. Responsibility for the statements posted lies with the person submitting the comment, not South Strand News.